top of page
About
Our Company
Our Leadership Team
Science
Our Technology
DNA Methylation
Exosomes
Products
Our Portfolio
Laboratory Developed Tests Services
Eye Care
Clinical Trial Drug Distribution
Health Supplements
Pipeline
Newsroom
Contact
Investors
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Publication
News
Leadership Story
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
Jul 24
YD Bio Expands U.S. Laboratory Footprint to 47 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Jul 8
YD Bio Limited Reports Full Year 2025 Financial Results
May 7
1
2
3
4
5
bottom of page
